Stocks Health care TECH
NASDAQ · Health careBIO-TECHNE Corp (TECH)
BIO-TECHNE Corp reported revenue of $1.2B in fiscal 2026, down 0.4% from a year earlier. Net income was $181.8M, a net margin of 15.0%. Operating cash flow minus capital spending left $263.2M of free cash flow in fiscal 2026. At June 30, 2026 it held $264.7M in cash against $200M of debt. Its latest periodic report to the SEC is the annual report (10-K) filed on August 24, 2026.
What BIO-TECHNE Corp does
BIO-TECHNE Corp is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker TECH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $1.2B | $181.8M | $1.16 | $263.2M |
| 2025 | $1.2B | $73.4M | $0.46 | $256.6M |
| 2024 | $1.2B | $168.1M | $1.05 | $236.1M |
| 2023 | $1.1B | $285.3M | $1.76 | $216.1M |
| 2022 | $1.1B | $272.1M | $1.66 | $280.4M |
| 2021 | $931M | $140.4M | $0.87 | $307.9M |
Latest SEC filings
What BIO-TECHNE Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 23, 2026
- September 14, 2026Additional proxy material DEFA14A
- September 14, 2026Other event 8-K
- September 9, 2026Additional proxy material DEFA14A
- September 2, 2026Additional proxy material DEFA14A
- August 25, 2026Additional proxy material DEFA14A
- August 24, 2026Annual report 10-K · period to June 30, 2026
- August 20, 2026Merger proxy statement DEFM14A
- August 12, 2026
- August 10, 2026Form PREM14A filing PREM14A
Questions about TECH
What does BIO-TECHNE Corp do?
BIO-TECHNE Corp is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker TECH.
Is BIO-TECHNE Corp profitable?
Yes. In fiscal 2026 it reported net income of $181.8M on revenue of $1.2B, a net margin of 15.0%.
How much revenue does BIO-TECHNE Corp make?
In fiscal 2026 BIO-TECHNE Corp reported revenue of $1.2B. That is 0.4% less than a year earlier.
When did BIO-TECHNE Corp last report?
Its most recent periodic report is the annual report (10-K) filed on August 24, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 24, 2026.
Similar companies
Follow TECH
Get an email when BIO-TECHNE Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow TECH: get an email when it filesWhere the numbers come from
Financial figures are the values BIO-TECHNE Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.